GHK-Cu

Accelerating

GHK-Cu appears in 105 indexed publications going back to 1983, including 23 in the past twelve months. 2 registered trials appear on ClinicalTrials.gov.

105

Indexed publications

Past 12 months, against 11 the year before

Registered clinical trials

622

Monthly readers on Wikipedia, up 10%

Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
2015	2
2016	3
2017	1
2018	3
2019	3
2020	9
2021	4
2022	3
2023	12
2024	6
2025	11
2026	21

Public Attention

Who is looking it up

Monthly readers of the GHK-Cu article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-082026-07

Clinical Trials

The registered pipeline

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase distribution across the most recently updated registered trials.

Not yet recruiting·Not applicable
Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults
LifeWave, Inc. · estimated completion 2027-04
Recruiting·Phase 2
Topical GHK-Cu Gel for Acute Skin Wound Healing
Hudson Biotech · estimated completion 2027-02-14

References

Most recent work

The newest indexed records mentioning GHK-Cu, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

2026-04-21·Bioactive materials
Microenvironment-responsive injectable dynamic hydrogel for sequential antioxidant and tissue regeneration therapy of radiation-induced skin injury
Yu X, Yang T, Bei Z et al.
2026-06-26·Materials today. Bio
Copper peptide activated cascade catalysis for glucose regulation and hypoxia reversing in infected diabetic wound healing
Huang ZJ, Huang RF, Jiao PP et al.
2026-06-29·Antioxidants (Basel, Switzerland)
A Torilis japonica Extract-GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis
Jeon S, Maeng J, Lee J et al.
2026-06-15·Biomaterials advances
Hierarchical regulation and mechanism of "open-hollow-fibrous network" structures: Osteogenic-angiogenic coupling responses of poly(γ-benzyl-L-glutamate) microspheres
Su J, Zhang Y, Cao Y et al.
2026-05-26·Research square
Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs
2026-05-05·Biogerontology
The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways
Wen H, Zhao K, Luo X et al.
2026-04-15·European journal of pharmacology
Glycyl-L-histidyl-L-lysine-Cu2+ (GHK-Cu) Attenuates CuSO4 or LPS induced-inflammation in Zebrafish larvae model
Hu J, Zhang C, Wang F. et al.
2026-04-22·Current issues in molecular biology
Multi-Target Restoration of Dermal Elastic Fibers Through Elastin Upregulation, Elastase Suppression, and Scaffold Reinforcement
Ye S, Kang S, Jeong ET et al.

In the Catalogue

GHK-Cu available from Polaris Research

GHK-Cu 50mg

Skin & Cosmetic

$0.99View product

Supplied as research materials for laboratory use. Free express delivery Australia wide.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-08-02.